Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical...
News
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
Partnership Brings Pioneering Approach to Incorporating Advanced Colorectal Cancer Detection Into Country’s Healthcare SystemBERKELEY, Calif. and MAINZ, Germany, Feb. 21,...
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
CAMBRIDGE, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
Randomized controlled trial designed to evaluate the safety and effectiveness of the Route 92 Medical 0.088” HiPoint Reperfusion Catheter, part...
REPEAT: New report exposes harmful impact of Ford government’s privatization scheme on local public hospitals: Health Coalition
Attn: Assignment EditorTORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- As the Ford government counters horror stories about unprecedented emergency department...
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
BRIDGEWATER, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical...
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
Topline Results Expected in Q2 2024This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics...
Delivra Health Brands’ Dream Water(R) Brand Launches its Sleep Gummies into the Canadian Market
Vancouver, British Columbia--(Newsfile Corp. - February 21, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or...
Bioz and Gamry Instruments Partner to Provide Customers With Product Validation Knowledge
PALO ALTO, CA / ACCESSWIRE / February 21, 2024 / Bioz, Inc., a leading Silicon Valley-based AI software company dedicated...
World-First Introduction of Home Oral Glucose Tolerance Testing Service for Gestational Diabetes Sees University Hospital Southampton Improve Test Accessibility and Yield Maximum User Preference Scores
OXFORD, UK / ACCESSWIRE / February 21, 2024 / Digital clinical diagnostics and diabetes home testing provider Digostics revealed today...
Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders
London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical...
RingCentral Announces Fourth Quarter and Fiscal Year 2023 Results
Total ARR up 11% to $2.33 billion Enterprise ARR up 13% to over $1 billion Record quarterly net cash provided...
NHI Announces First Quarter 2024 Dividend
MURFREESBORO, TN / ACCESSWIRE / February 20, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay...
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
The Waiver Exempts any determination of non-compliance associated to Nasdaq’s Minimum Bid Price Requirement RuleBELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences,...
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 20, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:...
Second-time Awardees CyncHealth, PointClickCare, Innsena Granted $80,000 Racial Equity in Postpartum Care Federal Funding
Department of Health and Human Services recognizes innovative program with proven outcomes for improving postpartum care for at-risk mothers in...
Cagent Vascular Raises $30 Million Series C Financing
Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only...
Harvard Eye Associates Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma
iDose® TR helps patients with glaucoma take long-term control of high eye pressureLAGUNA HILLS, CA / ACCESSWIRE / February 20,...
Mental Health Technologies (MHT) Patents SmarTest(TM) Technology
Automate Behavioral Health and Substance Use Screening Through MHT's SmarTest™ Platform.AURORA, IL / ACCESSWIRE / February 20, 2024 / Mental...